C

Cortechs.ai

Listed

Cortechs.ai provides AI-powered clinical decision support for neuroimaging, helping radiologists quantify brain changes in conditions like Alzheimer's disease.

About

Cortechs.ai provides AI-powered clinical decision support for neuroimaging, helping radiologists quantify brain changes in conditions like Alzheimer's disease.

Detailed overview

Overview

Cortechs.ai provides AI-powered software solutions for quantitative imaging analysis in neurological and oncological diseases. Their flagship product, NeuroQuant, offers brain segmentation and volumetric analysis to aid in the assessment and monitoring of neurodegenerative conditions. The company aims to optimize patient care through enhanced diagnostics and streamlined radiology workflows.

Key Features

  • NeuroQuant — Provides brain segmentation and volumetric analysis for neurodegenerative diseases.
  • NeuroQuant MS — Accurately visualizes and quantifies multiple sclerosis lesions and lesion volume changes.
  • NeuroQuant Brain Tumor — Offers pre- and post-operative 3D volume analysis of brain tumors.
  • NeuroQuant PET — Delivers rapid, automated regional tracer activity quantification.
  • NeuroQuant CT — Enables automated CT alignment for fast and accurate diagnosis.
  • OnQ Prostate — Optimizes prostate MRI for advanced clinical insights in prostate cancer detection and evaluation.
  • NeuroQuant Lesion Surveillance — Provides segmentation and longitudinal tracking of FLAIR, T2*GRE, and SWI lesions.

Who It's For

Cortechs.ai's solutions are designed for clinicians, radiologists, and medical institutions involved in diagnosing and monitoring neurological and oncological diseases. This includes hospitals, imaging centers, and research facilities that utilize MRI and CT scans for patient assessment. The software supports professionals in identifying and assessing conditions such as dementia, multiple sclerosis, brain tumors, and prostate cancer.

Notable Strengths

Cortechs.ai has processed over 2 million brain scans and is trusted by more than 1500 medical institutions across 44 countries. Their NeuroQuant product offers a Dynamic Atlas™ technology, validated over thousands of clinical cases, allowing for accurate analysis across ages 3-100. The company also highlights its support for Category III CPT codes (0865T, 0866T) for AI-assisted quantitative brain MRI analysis, facilitating reimbursement for providers.

Website link is available on the Verified plan